Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference

BOSTON, Sept. 3, 2024 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs, today announced that Joseph J. Ferra, Chief Executive Officer of Elevation Oncology, will participate in a fireside chat at the H.C. Wainwright 26^th Annual Global Investment Conference on Tuesday, September 10, 2024, at 11:30 am ET.